Ras GTPases play a crucial role in cell signaling pathways. Mutations of the Ras gene occur in about one third of cancerous cell lines and are often associated with detrimental clinical prognosis. Hot spot residues Gly12, Gly13, and Gln61 cover 97% of oncogenic mutations, which impair the enzymatic activity in Ras. Using QM/MM free energy calculations, we present a two-step mechanism for the GTP hydrolysis catalyzed by the wild-type Ras.GAP complex. We found that the deprotonation of the catalytic water takes place via the Gln61 as a transient Brønsted base. We also determined the reaction profiles for key oncogenic Ras mutants G12D and G12C using QM/MM minimizations, matching the experimentally observed loss of catalytic activity, thereby ...
Controlling the hydrolysis rate of GTP bound to guanine nucleotide binding proteins is crucial for t...
RAS mutants have been extensively studied as they are associated with development of cancer; however...
grantor: University of TorontoAbout 30% of human cancers are due to point mutations in one...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Controlling the hydrolysis rate of GTP bound to guanine nucleotide binding proteins is crucial for t...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Ras plays a major role as a molecular switch in many signal transduction pathways which lead to cell...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
AbstractRas plays a major role as a molecular switch in many signal transduction pathways which lead...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
SummaryThe flexibility of the conserved 57DTAGQ61 motif is essential for Ras proper cycling in respo...
(A) KRas4B is activated by the son of sevenless 1 (SOS1) nucleotide exchange factor (GEF), while GAP...
K-Ras is a small GTPase and acts as a molecular switch by recruiting GEFs and GAPs, and alternates b...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Controlling the hydrolysis rate of GTP bound to guanine nucleotide binding proteins is crucial for t...
RAS mutants have been extensively studied as they are associated with development of cancer; however...
grantor: University of TorontoAbout 30% of human cancers are due to point mutations in one...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Controlling the hydrolysis rate of GTP bound to guanine nucleotide binding proteins is crucial for t...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Ras plays a major role as a molecular switch in many signal transduction pathways which lead to cell...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
AbstractRas plays a major role as a molecular switch in many signal transduction pathways which lead...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
SummaryThe flexibility of the conserved 57DTAGQ61 motif is essential for Ras proper cycling in respo...
(A) KRas4B is activated by the son of sevenless 1 (SOS1) nucleotide exchange factor (GEF), while GAP...
K-Ras is a small GTPase and acts as a molecular switch by recruiting GEFs and GAPs, and alternates b...
Interest in the guanosine triphosphatase (GTPase) reaction of Ras as a molecular drug target stems f...
Controlling the hydrolysis rate of GTP bound to guanine nucleotide binding proteins is crucial for t...
RAS mutants have been extensively studied as they are associated with development of cancer; however...
grantor: University of TorontoAbout 30% of human cancers are due to point mutations in one...